(Q38560916)

4 September 2017

1 reference

title

Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death (English)

1 reference

4 September 2017

1 reference

1 reference

Prystowsky EN

1

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

American Journal of Cardiology

4 September 2017

published in

1 reference

4 September 2017

volume

78

1 reference

4 September 2017

issue

8A

1 reference

4 September 2017

page(s)

35-41

1 reference

Long-term results of DC reversion of atrial fibrillation

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Torsade de pointes due to quinidine: observations in 31 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Quinidine-induced long QTU interval and torsade de pointes: role of bradycardia-dependent early afterdepolarizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Amiodarone-induced polymorphous ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Procainamide-lnduced polymorphous ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Quinidine as a cause of sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Quinidine therapy of chronic auricular fibrillation. The occurrence and mechanism of syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

QUINIDINE-INDUCED SYNCOPE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Disopyramide-induced ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Torsade de pointes ventricular tachycardia a complication of disopyramide shared with quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Sotalol-induced torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Paroxysmal ventricular tachycardia and fibrillation due to quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

THE PROGNOSIS OF ATRIAL FIBRILLATION FOLLOWING MITRAL VALVOTOMY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Amiodarone-induced torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

SUCCESSFUL USE OF EXTERNAL ELECTRICAL CARDIOVERSION IN THE TREATMENT OF VENTRICULAR FIBRILLATION CAUSED BY QUINIDINE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Use of quinidine in treatment of chronic auricular fibrillation; results obtained in a series of one hundred fifty-five patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Propafenone-Induced Torsade de Pointes: Cross-Reactivity with Quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Flecainide-induced JT prolongation, T wave inversion and ventricular tachycardia during treatment for symptomatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Usefulness of propafenone for supraventricular arrhythmias in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Amiodarone and torsades de pointes in patients with advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

"Late" proarrhythmia due to quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Effects of pacing on triggered activity induced by early afterdepolarizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Magnesium therapy for torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Metabolic inhibition of ICa,L and IK differs in feline left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Prodromal ventricular premature beats preceded by a diastolic wave.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900564-4

10.1016/S0002-9149(96)00564-4

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference